Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $83.76 million. The enterprise value is $76.34 million.

Market Cap	83.76M
Enterprise Value	76.34M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Tharimmune has 35.04 million shares outstanding. The number of shares has increased by 272.29% in one year.

Current Share Class	35.04M
Shares Outstanding	35.04M
Shares Change (YoY)	+272.29%
Shares Change (QoQ)	+116.93%
Owned by Insiders (%)	4.05%
Owned by Institutions (%)	4.69%
Float	32.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.80
P/TBV Ratio	13.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.

Current Ratio	4.98
Quick Ratio	4.93
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-412.93

Financial Efficiency

Return on equity (ROE) is -225.01% and return on invested capital (ROIC) is -137.96%.

Return on Equity (ROE)	-225.01%
Return on Assets (ROA)	-99.79%
Return on Invested Capital (ROIC)	-137.96%
Return on Capital Employed (ROCE)	-167.98%
Revenue Per Employee	n/a
Profits Per Employee	-$3.44M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.16% in the last 52 weeks. The beta is 1.45, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+11.16%
50-Day Moving Average	2.96
200-Day Moving Average	2.15
Relative Strength Index (RSI)	39.94
Average Volume (20 Days)	823,302

Short Selling Information

The latest short interest is 746,766, so 2.13% of the outstanding shares have been sold short.

Short Interest	746,766
Short Previous Month	163,991
Short % of Shares Out	2.13%
Short % of Float	2.28%
Short Ratio (days to cover)	0.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.34M
Pretax Income	-10.32M
Net Income	-10.32M
EBITDA	n/a
EBIT	-10.34M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $7.61 million in cash and $195,493 in debt, giving a net cash position of $7.41 million or $0.21 per share.

Cash & Cash Equivalents	7.61M
Total Debt	195,493
Net Cash	7.41M
Net Cash Per Share	$0.21
Equity (Book Value)	6.15M
Book Value Per Share	0.85
Working Capital	6.15M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.72M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-272.29%
Shareholder Yield	-272.29%
Earnings Yield	-12.32%
FCF Yield	n/a

Analyst Forecast

The average price target for Tharimmune is $17.00, which is 611.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	611.30%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2